Here are three points:
1. The market is expected to hit $2.75 billion by 2025.
2. By 2025, the market is estimated to increase at a compound annual growth rate of 19.1 percent.
3. Increased government regulation on improved infection control practices, molecular diagnostic technological advancements and efforts to lower infections are spurring market growth.
More articles on quality and infection control:
10 top ASC citations from the Ohio Department of Health
Biocompatibles, guilty to misbranding, to pay $36M: 4 key notes
Coaching patients to ensure educated medical decisions: 6 observations
